Preregistration rotation including general practice

Por D'Cruz, David P
Publicado em 1985

Systemic lupus erythematosus

Por D'Cruz, David P
Publicado em 2006

Editorial: Cutting edge in systemic lupus erythematosus

Por D’Cruz, David P., Kuhn, Annegret
Publicado no Immunol Res (2017)

Controversies in the antiphospholipid syndrome: can we ever stop warfarin?

Por Fonseca, Ana G, D'Cruz, David P
Publicado em 2008

Mycophenolate mofetil in the treatment of lupus nephritis

Por Yong, Patrick FK, D’Cruz, David P
Publicado em 2008

Topical calcineurin inhibitors in systemic lupus erythematosus

Por Lampropoulos, Christos E, D’Cruz, David P
Publicado em 2010

The treatment of lupus nephritis: New and more conservative approaches in treatment are a major advance

Por D'Cruz, David P, Hughes, Graham R V
Publicado em 2005

Antiphospholipid (Hughes) syndrome: beyond pregnancy morbidity and thrombosis

Por Mialdea, Maria, Sangle, Shirish R, D'Cruz, David P
Publicado em 2009

Novel therapeutic agents in clinical development for systemic lupus erythematosus

Por Jordan, Natasha, Lutalo, Pamela MK, D’Cruz, David P
Publicado em 2013

Difficult asthma or Churg-Strauss syndrome? : Steroids may be masking undiagnosed cases of Churg-Strauss syndrome 

Por D’Cruz, David P, Barnes, Neil C, Lockwood, C Martin
Publicado em 1999

The role of B lymphocyte stimulator (BLyS) in systemic lupus erythematosus

Por Cancro, Michael P., D’Cruz, David P., Khamashta, Munther A.
Publicado em 2009

Infliximab in patients with systemic vasculitis that is difficult to treat: poor outcome and significant adverse effects

Por Sangle, Shirish R, Hughes, Graham R V, D'Cruz, David P
Publicado em 2007

The Hyperferritinemic Syndrome: macrophage activation syndrome, Still’s disease, septic shock and catastrophic antiphospholipid syndrome

Por Rosário, Cristina, Zandman-Goddard, Gisele, Meyron-Holtz, Esther G, D’Cruz, David P, Shoenfeld, Yehuda
Publicado em 2013

Pathogenic autoantibodies from patients with lupus nephritis cause reduced tyrosine phosphorylation of podocyte proteins, including tubulin

Por Manson, Jessica J, Mills, Kevin, Jury, Elizabeth, Mason, Lesley, D'Cruz, David P, Ni, Lan, Saleem, Moin, Mathieson, Peter, Isenberg, David, Rahman, Anisur
Publicado no Lupus Sci Med (2014)

Improved monitoring of clinical response in Systemic Lupus Erythematosus by longitudinal trend in soluble vascular cell adhesion molecule-1

Por Lewis, Myles J., Vyse, Simon, Shields, Adrian M., Zou, Lu, Khamashta, Munther, Gordon, Patrick A., Pitzalis, Costantino, Vyse, Timothy J., D’Cruz, David P.
Publicado no Arthritis Res Ther (2016)

Relationship between anti-dsDNA, anti-nucleosome and anti-alpha-actinin antibodies and markers of renal disease in patients with lupus nephritis: a prospective longitudinal study

Por Manson, Jessica J, Ma, Alexander, Rogers, Pauline, Mason, Lesley J, Berden, Jo H, Vlag, Johan van der, D'Cruz, David P, Isenberg, David A, Rahman, Anisur
Publicado em 2009

Immunoglobulin light chain allelic inclusion in systemic lupus erythematosus

Por Fraser, Louise D., Zhao, Yuan, Lutalo, Pamela M. K., D'Cruz, David P., Cason, John, Silva, Joselli S., Dunn‐Walters, Deborah K., Nayar, Saba, Cope, Andrew P., Spencer, Jo
Publicado no Eur J Immunol (2015)

Effects of belimumab, a B lymphocyte stimulator-specific inhibitor, on disease activity across multiple organ domains in patients with systemic lupus erythematosus: combined result...

Por Manzi, Susan, Sánchez-Guerrero, Jorge, Merrill, Joan T, Furie, Richard, Gladman, Dafna, Navarra, Sandra V, Ginzler, Ellen M, D'Cruz, David P, Doria, Andrea, Cooper, Simon, Zhong, Z John, Hough, Douglas, Freimuth, William, Petri, Michelle A
Publicado em 2012

A role for gut-associated lymphoid tissue in shaping the human B cell repertoire

Por Vossenkämper, Anna, Blair, Paul A., Safinia, Niloufar, Fraser, Louise D., Das, Lisa, Sanders, Theodore J., Stagg, Andrew J., Sanderson, Jeremy D., Taylor, Kirstin, Chang, Fuju, Choong, Lee M., D’Cruz, David P., MacDonald, Thomas T., Lombardi, Giovanna, Spencer, Jo
Publicado em 2013